The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
A Randomized Placebo-Controlled Pilot Trial of Omega-3 Fatty Acids and Alpha Lipoic Acid in Alzheimer's Disease
Open accessAbstract
Oxidative stress, inflammation, and increased cholesterol levels are all mechanisms that have been associated with Alzheimer's disease (AD) pathology. Several epidemiologic studies have reported a decreased risk of AD with fish consumption. This pilot study was designed to evaluate the effects of supplementation with omega-3 fatty acids alone (ω-3) or omega-3 plus alpha lipoic acid (ω-3 + LA) compared to placebo on oxidative stress biomarkers in AD. The primary outcome measure was peripheral F2-isoprostane levels (oxidative stress measure). Secondary outcome measures included performance on: Mini-Mental State Examination (MMSE), Activities of Daily Living/Instrumental Activities of Daily Living (ADL/IADL), and Alzheimer Disease Assessment Scale-cognitive subscale (ADAS-cog). Thirty-nine AD subjects were randomized to one of three groups: 1) placebo, 2) ω-3, or 3) ω-3 + LA for a treatment duration of 12 months. Eighty seven percent (34/39) of the subjects completed the 12-month intervention. There was no difference between groups at 12 months in peripheral F2-isoprostane levels (p = 0.83). The ω-3 + LA and ω-3 were not significantly different than the placebo group in ADAS-cog (p = 0.98, p = 0.86) and in ADL (p = 0.15, p = 0.82). Compared to placebo, the ω-3 + LA showed less decline in MMSE (p < 0.01) and IADL (p = 0.01) and the ω-3 group showed less decline in IADL (p < 0.01). The combination of ω-3 + LA slowed cognitive and functional decline in AD over 12 months. Because the results were generated from a small sample size, further evaluation of the combination of omega-3 fatty acids plus alpha-lipoic acid as a potential treatment in AD is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, preclinical studies and investigations in individuals affected by Alzheimer’s disease [132] provided evidence that ALA may promote neurocognitive enhancement via pleiotropic mechanisms, including antioxidant mitochondrial activity and anti-inflammatory properties [133]”
From Cognitive remission: a novel objective for the treatment of major depression? (2016) · cites this paper as [132]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
A new rating scale for Alzheimer's disease
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1356 · Cited by 4,175
An Inventory to Assess Activities of Daily Living for Clinical Trials in Alzheimerʼs Disease
Galasko, D., Bennett, D. A., Sano, M., Ernesto, C., Thomas, R., Grundman, M., & Ferris, S. H. (1997) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199700112-00005 · Cited by 1,198
Consumption of Fish and n-3 Fatty Acids and Risk of Incident Alzheimer Disease
Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., Bennett, D. A., Wilson, R. S., Aggarwal, N., & Schneider, J. (2003) · Archives of Neurology · doi:10.1001/archneur.60.7.940 · Cited by 1,135
Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential
Shay, K. P., Moreau, R. F., Smith, E. J., Smith, A. R., & Hagen, T. M. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.07.026 · Cited by 976
Dietary fat intake and the risk of incident dementia in the Rotterdam study
Kalmijn, S., Launer, L. J., Ott, A., Witteman, J. C. M., Hofman, A., & Breteler, M. M. B. (1997) · Annals of Neurology · doi:10.1002/ana.410420514 · Cited by 895 · cited 1×
“A number of epidemiologic studies have observed a consistent association of a decreased risk for AD and greater fish consumption [5–7].”
BackgroundThe pharmacology of the antioxidant lipoic acid
Biewenga, G. P., Haenen, G. R. M. M., & Bast, A. (1997) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(96)00474-0 · Cited by 848
Galasko, D. R., Bennett, D., Sano, M., Ernesto, C., Thomas, R., Grundman, M., & Ferris, S. H. (1997) · PubMed · Cited by 767
Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease: A Randomized Trial
Quinn, J. F., Raman, R., Thomas, R. G., Yurko-Mauro, K., Nelson, E. B., Van Dyck, C., Galvin, J. E., Emond, J., Jack, C. R., Weiner, M., et al. (2010) · JAMA · doi:10.1001/jama.2010.1510 · Cited by 764
Self-citationFreund-Levi, Y., Eriksdotter-Jönhagen, M., Cederholm, T., Basun, H., Faxén-Irving, G., Garlind, A., Vedin, I., Vessby, B., Wahlund, L.-O., & Palmblad, J. (2006) · Archives of Neurology · doi:10.1001/archneur.63.10.1402 · Cited by 751
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–289 of 289
The effects of bioactive compounds on Alzheimer’s disease and mild cognitive impairment
McAnany, B., & Martirosyan, D. M. (2016) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v6i6.257 · Cited by 8
Use of Phytochemicals against Neuroinflammation
Ong, W., Farooqui, T., Ho, C. F., Ng, Y., & Farooqui, A. A. (2017) · Wiley eBooks · doi:10.1002/9781119155195.ch1 · Cited by 9
Niazi, N. U. K., Jiang, J., Ou, H., Chen, R., & Yang, Z. (2025) · Brain Sciences · doi:10.3390/brainsci15060641 · Cited by 9
Fan, P., Liu, Y., Liu, C., Yao, H., Xu, S., Jiang, Y., Wu, Y., Liu, Y., & Guo, X. L. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2503342122 · Cited by 7
Rodríguez, A., Calero, O., Veiga, S., Menacho-Román, M., Arribas, I., Cano, L., García-Ribas, G., & Calero, M. (2025) · Alzheimer's Research & Therapy · doi:10.1186/s13195-025-01811-w · Cited by 8
Promising Functional Lipids for Therapeutic Applications
Paul, D., Dey, T. K., Chakraborty, A., & Dhar, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811448-3.00013-9 · Cited by 7
Wal, P., Vig, H., Khare, R., Wal, A., Tondon, G., Kishore, A., & Kumar, S. (2023) · The Open Medicinal Chemistry Journal · doi:10.2174/18741045-v17-e230916-2023-8 · Cited by 9
The emerging role of disulfidptosis in Alzheimer's disease
Zhou, Q., Zheng, N., Chen, Z., Xie, L., Yang, X., Sun, Q., Lin, J., Li, B., & Li, L. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178085 · Cited by 10
Cuciniello, R., Luongo, D., Maurano, F., Crispi, S., & Bergamo, P. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.01.006 · Cited by 6
Manavi, M. A., Nourhashemi, M., Emami, S., Nasab, M. H. F., Dehnavi, F., Küçükkılınç, T. T., Foroumadi, A., Sharifzadeh, M. S., & Khoobi, M. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108241 · Cited by 6
Pasupuleti, R. R., Tsai, P., Ponnusamy, V. K., & Chen, N.-C. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2021.132685 · Cited by 6
Kohatsu, W., & Karpowicz, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35868-2.00088-8 · Cited by 6
Liu, Y., Chen, S., Li, S., Pei, Z., Fan, S., & Guo, Y. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251362444 · Cited by 6
Khatun, P., Li, X., Xiao-xi, Z., Zhai, J., Ullah, A., Bo, Y., & Lyu, Q. (2025) · Nutrition Reviews · doi:10.1093/nutrit/nuaf167 · Cited by 7
Abuknesha, N. R., O’Keefe, J. H., Qian, F., Tintle, N., Lin, Y., Sun, Y., Qian, H., Aisen, P. S. S., Albert, C. M., Aronson, W. J., et al. (2026) · Proceedings of The Nutrition Society · doi:10.1017/s0029665126102493 · Cited by 6
Self-citationToxicity of the spike protein of COVID-19 is a redox shift phenomenon: A novel therapeutic approach
Schwartz, L. H., Aparicio-Alonso, M., Henry, M., Radman, M., Attal, R., & Bakkar, A. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.05.034 · Cited by 6
Soluble Epoxide Hydrolase Deletion Limits High-Fat Diet-Induced Inflammation
Wagner, K. M., Yang, J., Morisseau, C. H. P., & Hammock, B. D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.778470 · Cited by 5
Omega-3 Fatty Acids and Cognitive Behavior
Giles, G. E., Mahoney, C. R., & Kanarek, R. B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815238-6.00020-1 · Cited by 5
Ovarian Hormone-Dependent Effects of Dietary Lipids on APP/PS1 Mouse Brain
Herrera, J. L., Ordóñez‐Gutiérrez, L., Fabriàs, G., Casas, J., Morales, A., Hernández, G., Acosta, N. G., Rodríguez, C., Prieto, L., García‐Segura, L. M., et al. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00346 · Cited by 5
Güven, A., Dalgınlı, K. Y., Çulhaoğlu, H., Hüseyinoğlu, N., & İlhan, S. (2020) · Kafkas Journal of Medical Sciences · doi:10.5505/kjms.2020.89801 · Cited by 5
Lara, H. H., Alanís-Garza, E. J., Puente, M. F. E., Mureyko, L., Torres, D. A. A., & Ixtepan-Turrent, L. (2015) · PubMed · Cited by 5
Saeed, R. M. A., Ahmed, H. H., Saleh, A. A. S., & Ahmed, Y. S. (2017) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v16i9.17 · Cited by 5
REVIEW ON THERAPEUTIC EFFECTS MEDIATED BY OMEGA-3 FATTY ACIDS IN ALZHEIMER’S DISEASE
Sati, A., & Priyanka, B. (2018) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2018.v11i2.22435 · Cited by 5
Therapeutic potential of clinically proven natural products in the management of dementia
Ansari, F., Sohel, M., Haidary, M. M. H., Mostaq, M. S., Akter, S., Nahar, A. K. M. M. H. B. L., Zohora, F., Ahmed, A., Hasan, M. S., Babu, M. H., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27233 · Cited by 4
α‑lipoic acid can greatly alleviate the toxic effect of AGES on SH‑SY5Y cells
Niu, G., Guo, J., Tian, Y., Zhao, K., Li, J., & Xiao, Q. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3477 · Cited by 4
Singh, H., Thakur, S., Sahajpal, N., Singh, H., Singh, A., Sohal, H. S., & Jain, S. K. (2020) · Current Drug Delivery · doi:10.2174/1567201817666200512103402 · Cited by 4
Méndez, A. A., Aguilera-Manuel, K., Saavedra‐Molina, A., Ríos‐Chávez, P., Villafaña, S., Nieto-Aguilar, R., Godínez‐Hernández, D., Ortega-Cuéllar, D., Palomera‐Sánchez, Z., & Gauthereau‐Torres, M. Y. (2026) · Neurology International · doi:10.3390/neurolint18040064 · Cited by 3
Cao, M., Yang, F., Guo, Y., Liu, R., Chang, M., Wang, Y., Wei, W., Jin, Q., & Wang, X. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.104066 · Cited by 6
Niazi, S. K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810211 · Cited by 3
Role of Nutraceuticals in Dementia Care
Ford, J. M., & Brandt, N. (2014) · Journal of Gerontological Nursing · doi:10.3928/00989134-20140304-99 · Cited by 3
Lin, J., Dong, B., & Vellas, B. J. (2016) · The journal of nutrition health & aging · doi:10.1007/s12603-016-0724-z · Cited by 2
Treatment of Dementia: Pharmacological Approaches
Brandt, N., & Mansour, D. Z. (2015) · Springer eBooks · doi:10.1007/978-3-319-18377-0_6 · Cited by 2
Puerto, A. M. H., Russo, C., & Fregni, F. (2018) · Neuromethods · doi:10.1007/978-1-4939-7880-9_9 · Cited by 5
UPDATE ON PREVENTION TRIALS IN ALZHEIMER’S DISEASE
Vellas, B. J. (2014) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2014.30 · Cited by 3
Beversdorf, D. Q., Crosby, H. W., & Shenker, J. I. (2023) · PubMed Central · Cited by 3
Musich, M. L., Shenker, J. I., & Beversdorf, D. Q. (2026) · Journal of dementia and Alzheimer's disease · doi:10.3390/jdad3010004 · Cited by 2
Bukowiecka‐Matusiak, M., Burzyńska-Pędziwiatr, I., Szczęsna, D., Chmielewska-Kassassir, M., Fabijan, A., & Woźniak, L. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816918-6.00023-8 · Cited by 2
Коган, М. И., & Jeong, H.-S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35868-2.00011-6 · Cited by 2
"Cognition and Omega-3 Fatty Acids: A Narrative Review of the Literature"
Javier, G. (2021) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2021.40.006488 · Cited by 2
Matysek, A., Kimmantudawage, S. P., Feng, L., & Maier, A. B. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.898853 · Cited by 2
Novel mutations and molecular pathways identified in patients with brain iron accumulation disorders
Si, L., Wang, Z., Li, X., Yang, S., Yao, T., Xu, E., Wang, X., & Wang, C. (2023) · Neurogenetics · doi:10.1007/s10048-023-00725-9 · Cited by 2
Arsecularatne, A., Kapini, R., Liu, Y., Chang, D., Münch, G. W., & Zhou, X. (2024) · Biomedicines · doi:10.3390/biomedicines12061237 · Cited by 2
Longitudinal study of seafood and fish oil supplement intake and risk of persistent tinnitus
Curhan, S. G., Zeleznik, O. A., & Curhan, G. C. (2024) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2024.09.028 · Cited by 3
THERAPEUTIC USE OF ALPHA-LIPOIC ACID SUPPLEMENTATION: A REVIEW ON CURRENT USE AND FUTURE PROSPECTIVE
Taha, M. (2024) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2024v16i6.51319 · Cited by 4
Shi, H., & Xu, J. (2021) · Scientia Sinica Vitae · doi:10.1360/ssv-2021-0196 · Cited by 3
Smith, F. (2022) · Springer eBooks · doi:10.1007/978-3-031-13388-6_8 · Cited by 2
d’Arqom, A., Nasution, M. Z., Kadir, S. Z. S. A., Yusof, J., & Govindaraju, K. (2023) · F1000Research · doi:10.12688/f1000research.129045.2 · Cited by 3
Sphingolipid imbalance aggravates tau pathology by endomembrane rigidification and rupturePreprint
Tittelmeier, J., Sandhof, C. A., Martin, N., El-Kabarity, D., Ngonza-Nito, S.-B., Melki, R., & Nussbaum-Krammer, C. I. (2025) · eLife · doi:10.7554/elife.106865.1 · Cited by 2
Abuknesha, N. R., O’Keefe, J. H., Qian, F., Tintle, N. L., Lin, Y., Sun, Y., Qian, H.-Z., Aisen, P. S., Albert, C. M., Aronson, W. J., et al. (2026) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.125.014785 · Cited by 1
“%) or triglyceride-based formulation 72,82–84, 86 , 93 , 94, 96, 98–100,102”
Self-citationNeroev, V. V., Pavlenko, T. A., Chesnokova, N. B., Валерьевна, Б. О., Okhotsimskaya, T. D., & Panova, A. Y. (2024) · Russian Ophthalmological Journal · doi:10.21516/2072-0076-2024-17-1-74-82 · Cited by 1
ALSUntangled #79: alpha-lipoic acid
Giacobbe, A., Hiana, J. C., Wang, O., Benatar, M. G., Wicks, P. J., Cadavid, J. M., Jhooty, S., McDermott, C. J., Pattee, G. L., Bertorini, T. E., et al. (2025) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2025.2507166 · Cited by 2
Role of Omega-3 and Omega-6 Fatty Acids Against Alzheimer’s Disease
Banerjee, S., Nirala, N., Kumar, P., & Banerjee, S. (2025) · Nutritional neurosciences · doi:10.1007/978-981-95-2736-6_10 · Cited by 1
The Brain-Heart-Kidney Axis: a unified theory of systemic small vessel disease in CSVD
Li, T., Liu, J., & Zhuo, C. (2025) · Medical Hypotheses · doi:10.1016/j.mehy.2025.111774 · Cited by 1
The iron-energy metabolism axis in Alzheimer’s pathogenesis: from mechanisms to interventions
Zou, Z., Chen, J., Li, J., & Zou, Z. (2026) · Cell Death Discovery · doi:10.1038/s41420-026-03034-w · Cited by 2
Galangin modulates the NRF2/PPAR-Γ pathway, attenuating sepsis-induced tissue damage in the lungs
Aydın, P., Toktay, E., Çadırcı, E., & Halıcı, Z. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11931-7 · Cited by 1
Aryl Hydrocarbon Receptor Signaling in Aging: A Key Modulator of Brain Homeostasis
Juárez-Solano, H., Martínez‐Coria, H., Pérez‐Osorio, I. N., Hernández-Esquivel, R. A., & Torres-Ramos, M. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05874-0 · Cited by 1
Efficacy of antioxidants as a therapy for Alzheimer's disease: a meta-analysis
Li, J., Chen, B., Jiang, J., Feng, Y., Zhang, R., Li, D. M., Wang, R., Long, Z., Ge, L., Guo, Y., et al. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1878597 · Cited by 1
Omega-3 fatty acids and neurodegenerative diseases: Focus on Alzheimer's disease
Niazi, N. U. K., & Cai, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-21800-2.00020-8 · Cited by 1
Antioxidants and their possible benefits in neurodegeneration
Jha, K. T., Chawla, V., Roy, G. S., & Chawla, P. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13474-6.00024-x · Cited by 1
Study of fat and organic acids in feverfew cultivars White Gem and Phlora Pleno herb
Hordiei, K. R., Гонтова, Т. М., & Гапоненко, В. П. (2020) · Ukrainian biopharmaceutical journal · doi:10.24959/ubphj.20.286 · Cited by 1
Neurocognitive Functions and Lipids
Sharafkhaneh, H. (2016) · Elsevier eBooks · doi:10.1016/b978-1-63067-036-8.00016-0
Whole Body Synthesis of Docosahexaenoic Acid from Alpha-Linolenic Acid in Rodents
Domenichiello, A. F. (2015) · TSpace (University of Toronto)
Miller, B. (2015) · Arizona State University Library Digital Repository (Arizona State University)
Fernández, S. S. M. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.89.2016.tde-19102016-165329
Liponerv – nowe możliwości pomocy chorym z łagodnymi zaburzeniami poznawczymi
Qpharma Sp. z o.o., W., & Dżumaga, B. (2017) · Psychiatria i Psychologia Kliniczna · doi:10.15557/pipk.2017.0008
Alzheimer, Ultimas Investigaciones
(2015) · OMICS International eBooks · doi:10.4172/978-1-63278-057-7-058
Gerassimakis, C. (2017) · Library, Museums and Press - UDSpace (University of Delaware) · doi:10.58088/s1j6-3e94
Desport, J., Jésus, P., & Fayemendy, P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804607-4.00005-8
Interactions Between Age, Diet, and Insulin and Their Effect on Cognition
Félix‐Soriano, E., Moreno-Aliaga, M. J., Ramírez, M. J., & Solas, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811959-4.00014-6
Anti-Inflammatory Nutrients and Nutraceuticals for Active and Healthy Aging
Goudarzi, S., & Abdollahi, M. R. (2020) · Springer eBooks · doi:10.1007/978-981-15-3552-9_8
Митохондриальные нарушения при болезни Альцгеймера
Sukhorukov, V. S., Mudzhiri, N. M., Voronkova, A. S., Baranich, T. I., Glinkina, V. V., & Illarioshkin, S. N. (2021) · Biochemistry (Moscow) · doi:10.31857/s0320972521060051
(2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811351-6.00026-7
Mechanisms of Thai medicinal plant extracts on the attenuation of glutamate-mediated neurotoxicity
Prasansuklab, A. (2017) · Chula Digiverse · doi:10.58837/chula.the.2017.156
Functional food for mitochondrial dysfunction and autophagy in neurodegenerative diseases
Dagar, K., Asati, V., Bharti, S. K., Suryavanshi, A., Shukla, D., Mahapatra, D. K., & Kumar, V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18951-7.00003-7
Blood EPA and DHA status among people living in the United States from 2000 to 2023
Gründler, L., Beinhorn, P., Hahn, A., & Schuchardt, J. P. (2024) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2024.102653
Tittelmeier, J., Sandhof, C. A., Martin, N., El-Kabarity, D., Ngonza-Nito, S.-B., Melki, R., & Nussbaum-Krammer, C. I. (2025) · eLife · doi:10.7554/elife.106865
Fan, L., Chen, S., Bu, Y., Liu, Z., Wang, S., Zhang, W., He, Y., Zhang, Y., & Sun, D. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.109995
Yan, Z., Xu, Y., Peng, T., & Du, X. (2025) · Biogerontology · doi:10.1007/s10522-025-10294-z · Cited by 1
Omega-3 Fatty Acids and Brain Health: One Size Does Not Fit All
Kotchetkov, A., & Kamel, M. (2025) · Food and Nutrition Sciences · doi:10.4236/fns.2025.1610082
Sychrová, A. (2025) · Česká a slovenská farmacie · doi:10.36290/csf.2025.042
Fernando, M. G., Sullivan, K. E., Simons, M., Squillace, A., Kiat, H., & Martins, R. N. (2026) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2026.101434 · Cited by 1
Reinapu, A., Kirss, S., Tõugu, V., & Palumaa, P. (2026) · ACS Omega · doi:10.1021/acsomega.6c04498
Sayed, M. A., Said, A., & Meselhy, M. (2026) · BMC Geriatrics · doi:10.1186/s12877-026-08126-x
Li, X., Jin, Y., Li, X., Chen, M., Kang, C., Lu, H., Gao, H., & Jiang, X. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108479
BindingDB (2017) · UC San Diego · doi:10.7270/q2w66nnd
Investigation of BACE1 as a stress-induced regulator of neuronal metabolism
Findlay, J. A. (2014) · Discovery Research Portal (University of Dundee)
Metadata
- Authors
- Shinto, L., Quinn, J., Montine, T., Dodge, H. H., Woodward, W., Baldauf-Wagner, S., Waichunas, D., Bumgarner, L., Bourdette, D., Silbert, L., & Kaye, J.
- Affiliations
- Oregon Health & Science University (US)
- University of Washington (US)
- Corresponding author
- Shinto, Lynne
- ORCID
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2013-10-29
- Volume
- 38
- Issue
- 1
- Pages
- 111-120
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC3886557
- OpenAlex
- W1528771930
- Cited by
- 288
- References
- 38
- Citations by year
- 2026: 12 · 2025: 28 · 2024: 19 · 2023: 30 · 2022: 20 · 2021: 25 · 2020: 32 · 2019: 16 · 2018: 19 · 2017: 19 · 2016: 24 · 2015: 25 · 2014: 13
- FWCI
- 19.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Alzheimer s Disease (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion, cc-by-nc)
- PubMed Central (acceptedVersion, cc-by-nc)
- Funders
- National Institutes of Health (AG‐08017)
- National Institute on Aging (AG 08017, P30AG008017, R21AG023805)
- National Center for Research Resources (M01RR00334, M01RR000334, UL1RR024140)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, omega-3 fatty acids
- MeSH terms
- Activities of Daily Living, Aged, Aged, 80 and over, Alzheimer Disease, Analysis of Variance, Cognition Disorders, Double-Blind Method, Female, Humans, Thioctic Acid, Male, Mental Status Schedule, Middle Aged, Pilot Projects, Fatty Acids, Omega-3, Outcome Assessment, Health Care, F2-Isoprostanes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
